News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
WALSH MATTHEW M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/08/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2023 |
4
| WALSH MATTHEW M (Director) has filed a Form 4 on Certara, Inc.|
Txns:
| Granted 8,663 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| WALSH MATTHEW M (Director) has filed a Form 4 on Certara, Inc.|
Txns:
| Exercised 9,067 restricted stock units
@ $0 |
|
| 05/08/2023 |
4
| WALSH MATTHEW M (CFO) has filed a Form 4 on Organon & Co.|
Txns:
| Paid exercise price by delivering 4,043 shares
@ $24.24, valued at
$98k
Exercised 8,310 restricted stock units
@ $0 |
|
| 04/04/2023 |
4
| WALSH MATTHEW M (CFO) has filed a Form 4 on Organon & Co.|
Txns:
| Paid exercise price by delivering 2,656 shares
@ $23.09, valued at
$61.3k
Exercised 7,753 restricted stock units
@ $0
Granted 36,139 restricted stock units
@ $0
Granted 129,770 options to buy
@ $23.52, valued at
$3.1M
|
|
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/09/2022 |
4
| WALSH MATTHEW M (CFO) has filed a Form 4 on Organon & Co.|
Txns:
| Paid exercise price by delivering 10,790 shares
@ $32.41, valued at
$349.7k
Exercised 22,343 restricted stock units
@ $0 |
|
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| WALSH MATTHEW M (CFO) has filed a Form 4 on Organon & Co.|
Txns:
| Granted 23,260 restricted stock units
@ $0
Granted 71,649 options to buy
@ $34.93, valued at
$2.5M
|
|
| 08/19/2021 |
4
| WALSH MATTHEW M (CFO) has filed a Form 4 on Organon & Co.|
Txns:
| Granted 44,642 options to buy
@ $35.38, valued at
$1.6M
|
|
| 08/09/2021 |
4
| WALSH MATTHEW M (CFO) has filed a Form 4 on Organon & Co.|
Txns:
| Exercised 22,343 shares
@ $28.63, valued at
$639.7k
Paid exercise price by delivering 7,653 shares
@ $28.63, valued at
$219.1k
Exercised 22,343 restricted stock units
@ $0 |
|
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/16/2020 |
4
| WALSH MATTHEW M (Director) has filed a Form 4 on Certara, Inc.|
Txns:
| Acquired 22,304 shares
@ $0
Granted 145,597 shares
@ $0
Bought 5,000 shares
@ $23, valued at
$115k
|
|
| 12/11/2020 |
3
| WALSH MATTHEW M (Director) has filed a Form 3 on Certara, Inc. |
| 05/11/2020 |
4
| WALSH MATTHEW M (EVP, CFO) has filed a Form 4 on Allergan plc|
Txns:
| Disposed/sold 12,039 shares
@ $0
Disposed/sold 27,618 restricted stock units
@ $0
Disposed/sold 28,021 rights
@ $0 |
|
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2018 |
4
| WALSH MATTHEW M (EVP, CFO) has filed a Form 4 on Allergan plc|
Txns:
| Bought 1,000 shares
@ $153.96, valued at
$154k
|
|
| 02/22/2018 |
4
| WALSH MATTHEW M (EVP, CFO) has filed a Form 4 on Allergan plc|
Txns:
| Granted 13,076 shares
@ $160.59, valued at
$2.1M
Granted 9,340 shares
@ $160.59, valued at
$1.5M
Bought 2,000 shares
@ $160.94, valued at
$321.9k
Granted 28,021 options to buy
@ $0 |
|
| 02/21/2018 |
3
| WALSH MATTHEW M (EVP, CFO) has filed a Form 3 on Allergan plc |
| 08/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2017 |
4
| WALSH MATTHEW M (EVP & CFO) has filed a Form 4 on Catalent, Inc.|
Txns:
| Paid exercise price by delivering 3,230 shares
@ $34.97, valued at
$113k
|
|
| 07/26/2017 |
4
| WALSH MATTHEW M (See Remarks) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 5,275 shares
@ $0
Granted 27,378 options to buy
@ $36.02, valued at
$986.2k
|
|
| 06/12/2017 |
4
| WALSH MATTHEW M (See Remarks) has filed a Form 4 on Catalent, Inc.|
Txns:
| Paid exercise price by delivering 46,903 shares
@ $37.0086, valued at
$1.7M
Sold 24,989 shares
@ $0
Sold 2,759 shares
@ $0
Exercised 54,277 options to buy
@ $10.71, valued at
$581.3k
Exercised 20,374 options to buy
@ $14.86, valued at
$302.8k
|
|
| 10/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/13/2016 |
4
| WALSH MATTHEW M (See Remarks) has filed a Form 4 on Catalent, Inc. |
| 07/28/2016 |
4
| WALSH MATTHEW M (See Remarks) has filed a Form 4 on Catalent, Inc. |
| 06/01/2016 |
4
| WALSH MATTHEW M (See Remarks) has filed a Form 4 on Catalent, Inc.|
Txns:
| Paid exercise price by delivering 13,082 shares
@ $28.85, valued at
$377.4k
Sold 4,418 shares
@ $28.85, valued at
$127.5k
Paid exercise price by delivering 39,245 shares
@ $28.85, valued at
$1.1M
Sold 13,255 shares
@ $28.85, valued at
$382.4k
Paid exercise price by delivering 15,600 shares
@ $28.85, valued at
$450.1k
Sold 3,524 shares
@ $28.85, valued at
$101.7k
Exercised 17,500 options to buy
@ $14.86, valued at
$260.1k
Exercised 52,500 options to buy
@ $14.86, valued at
$780.2k
Exercised 19,124 options to buy
@ $18.71, valued at
$357.8k
|
|
| 10/05/2015 |
4
| WALSH MATTHEW M (Director) has filed a Form 4 on MULTI COLOR Corp|
Txns:
| Granted 860 shares
@ $0 |
|
| 09/04/2015 |
4
| WALSH MATTHEW M (See Remarks) has filed a Form 4 on Catalent, Inc.|
Txns:
| Granted 9,562 options to buy
@ $18.71, valued at
$178.9k
|
|
|
|
|